Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targetsJing Hua Zhao, James E. Peters, David Stacey et al.|Nature Immunology|2023Cited by 724
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkersGiovanni B. Frisoni, Bengt Winblad, Marina Boccardi et al.|The Lancet Neurology|2017Cited by 630
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Richard O’Brien, Ulf Andréasson et al.|Alzheimer s & Dementia|2011Cited by 412
Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid testsNicolas R Barthélemy, Oskar Hansson, Gemma Salvadó et al.|Nature Medicine|2024Cited by 401
CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Olivier Bousiges, Ulf Andréasson et al.|Alzheimer s & Dementia|2013Cited by 386